Huilin Ma

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Combination Therapy

Mass Spectrometry

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Hanwen Wang, Huilin Ma, Richard J Sové, Leisha A Emens, Aleksander S Popel
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer. Journal for immunotherapy of cancer 9 (2) (2022)
Huilin Ma, Hanwen Wang, Richard J Sové, Jun Wang, Craig Giragossian, Aleksander S Popel
Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model. Journal for immunotherapy of cancer 8 (2) (2021)